Caredx Inc [CDNA] stock is trading at $18.9, up 2.00%. An important factor to consider is whether the stock is rising or falling in short-term value. The CDNA shares have gain 10.01% over the last week, with a monthly amount glided 25.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Wells Fargo upgraded its rating to Equal Weight on January 15, 2025, and dropped its price target to $24. On August 28, 2024, Wells Fargo initiated with a Underweight rating and assigned a price target of $28 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $40 on August 19, 2024. Raymond James downgraded its rating to a Mkt Perform. Craig Hallum upgraded its rating to Buy for this stock on May 01, 2024, but kept the price target unchanged to $15. In a note dated November 09, 2023, Stephens upgraded an Overweight rating on this stock but restated the target price of $10.
Caredx Inc [CDNA] stock has fluctuated between $10.96 and $25.95 over the past year. Currently, Wall Street analysts expect the stock to reach $28.8 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $18.9 at the most recent close of the market. An investor can expect a potential return of 52.38% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
Caredx Inc [NASDAQ:CDNA] reported sales of 358.00M for the trailing twelve months, which represents a growth of 20.72%. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.17 and Total Capital is 0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.51 points at the first support level, and at 18.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.14, and for the 2nd resistance point, it is at 19.39.
Ratios To Look Out For
For context, Caredx Inc’s Current Ratio is 3.03. On the other hand, the Quick Ratio is 2.75, and the Cash Ratio is 0.92. Considering the valuation of this stock, the price to sales ratio is 2.72, the price to book ratio is 3.12 and price to earnings (TTM) ratio is 15.85.
Transactions by insiders
Recent insider trading involved Novack Jeffrey Adam, Secretary and General Counsel, that happened on Dec 04 ’25 when 7293.0 shares were sold. Officer, JEFFREY NOVACK completed a deal on Dec 04 ’25 to buy 7293.0 shares. Meanwhile, Secretary and General Counsel Novack Jeffrey Adam sold 2688.0 shares on Nov 07 ’25.
